a.batista
TL2 · Nantes
Contributes reviews on supplier material. Based in Nantes.
Joined 29 January 2025 · last posted 10d
76 posts, newest first. Showing up to 150.
-
Submitting a sample: the process end to end Replied, post #90 · Sourcing › Independent verification · 17 Jul 2026 · 21 likes I have three months of notes on submitting a sample and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
-
Common supplements people ask about, assessed one at a time Replied, post #33 · Practice › Interactions · 11 Jul 2026 · 0 likes Adding a null result on common supplements. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #3 · Practice › Interactions · 1 Jul 2026 · 0 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
A pooled estimate that changed when one trial was added Replied, post #15 · Evidence › Meta-analyses · 27 Jun 2026 · 20 likes When trials differ in population, duration and comparator, the pooled estimate answers a question no individual trial asked. That is worth saying before the number is…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #64 · Analytics › Home & field testing · 22 Jun 2026 · 4 likes Immunoassay limitations: tests that use antibodies have cross-reactivity limitations. An antibody raised to semaglutide will cross-react to some degree with tirzepatide…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #4 · Practice › Dosing & titration · 18 Jun 2026 · 0 likes Post #2 and I disagree about the size of the effect, not about the direction. Concentration and dose get conflated constantly in this subcategory. Changing how much…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #25 · Start Here › Welcome · 16 Jun 2026 · 23 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Racemisation and why it is invisible to a mass measurement Replied, post #106 · Analytics › Impurities & related substances · 14 Jun 2026 · 0 likes Picking up post #104: that is the part I would want checked first. Related substances: compounds chemically related to the target peptide but not the target peptide…
-
Semaglutide and alcohol: what is actually documented Replied, post #8 · Compounds › Semaglutide · 7 Jun 2026 · 21 likes Two people in this thread mean different things by semaglutide and alcohol and are disagreeing about the definition while believing they are disagreeing about the…
-
Submitting a sample: the process end to end Replied, post #3 · Sourcing › Independent verification · 5 Jun 2026 · 0 likes I would be cautious about generalising from the submitting a sample example above. It is a good example. It is one example.
-
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Replied, post #23 · Compounds › Oral incretins · 5 Jun 2026 · 0 likes Building on post #21 rather than restating it. PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was…
-
Coming back to: When a red flag was a misunderstanding, and the retraction Replied, post #6 · Sourcing › Red flags · 31 May 2026 · 0 likes Where the red flag reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Follow-up: Search filters: what is missing Replied, post #114 · Meta › Site feedback · 29 May 2026 · 5 likes Search filters came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Dizziness on standing: the ordinary explanation first — one year on Replied, post #7 · Nutrition & Training › Hydration & electrolytes · 28 May 2026 · 19 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #33 · Clinical › Comorbidities · 27 May 2026 · 0 likes Following this. I have the same question and no better information than the first post.
-
Programming during a large energy deficit Replied, post #2 · Nutrition & Training › Resistance training · 19 May 2026 · 0 likes A note on how programming during a large energy gets discussed rather than on programming during a large energy itself: the confident posts get the replies and the…
-
A revision dispute resolved on the topic rather than in the history Replied, post #2 · Meta › Wiki maintenance · 7 May 2026 · 18 likes The convention is to label them explicitly as community practice in the sentence. It is not always applied, and where it is not, that is a defect rather than a style…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #14 · Analytics › Home & field testing · 29 Apr 2026 · 28 likes The practical version of home kit substitute is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
The best-written scientific paper you have read Replied, post #5 · Lounge › Off topic · 14 Apr 2026 · 4 likes Loosely related and not worth its own topic: the vocabulary here has leaked into how I read everything. I now notice when a press release gives a relative figure and no…
-
Research-use-only status: what it means legally and practically Replied, post #25 · Compounds › Other compounds · 9 Apr 2026 · 0 likes The reason research-use-only status keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is…
-
Washout with a one-week half-life: the arithmetic — does this still hold? Replied, post #3 · Research Methods › N-of-1 designs · 31 Mar 2026 · 0 likes Committing to post the result before you know it is a useful precommitment, and this subcategory is a reasonable place to make it. A partial answer, offered because a…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #101 · Research Methods › N-of-1 designs · 25 Mar 2026 · 33 likes Multiple outcomes measured without a primary one means something will move. Nominate the primary in advance and report the rest as secondary. The literature is thinner…
-
Oral semaglutide bioavailability and its variability between people Replied, post #43 · Compounds › Oral incretins · 21 Mar 2026 · 0 likes Narrowing post #40, because the general version has more than one answer. Orforglipron is a small molecule rather than a peptide, which changes almost everything about…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #41 · Research Methods › N-of-1 designs · 10 Mar 2026 · 0 likes A single-person experiment can be genuinely informative if it has a pre-specified outcome, a defined period, and a plan written before the data arrives. Most accounts…
-
The lowest dose that does anything: is that a real question? Replied, post #75 · Practice › Dosing & titration · 6 Mar 2026 · 32 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Grapefruit: why this class is not the class that cares Replied, post #11 · Practice › Interactions · 4 Mar 2026 · 8 likes The version of grapefruit that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
[2026 update] Availability by country, dated, with primary sources Replied, post #22 · Access › International · 5 Feb 2026 · 0 likes On Availability: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #49 · Documentation › Wiki requests · 22 Jan 2026 · 7 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important.
-
Documentation that appears only after payment Replied, post #118 · Sourcing › Red flags · 26 Dec 2025 · 27 likes Taking post #117 at face value and following it one step further. On documentation: the maintained page in the documentation commons covers the general case with…
-
How to read a forest plot, properly, from scratch Replied, post #76 · Evidence › Trials · 26 Dec 2025 · 7 likes On post #73 — agreed on the reasoning, with one qualification. Absolute and relative effects answer different questions. Write down the event rate in each arm and the…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #13 · Pharmacology › Receptor biology · 15 Dec 2025 · 0 likes On post #9 — agreed on the reasoning, with one qualification. Nothing in receptor biology tells you what is in the vial, which is worth remembering when a mechanistic…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #49 · Clinical › Special populations · 10 Dec 2025 · 1 like Everything in post #45 holds. The case it does not cover is the one I have. The thing about older adults that took me longest to accept is that a plausible mechanism is…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #26 · Sourcing › Independent verification · 28 Nov 2025 · 20 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured.
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #15 · Practice › Reconstitution · 23 Nov 2025 · 5 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #10 · Compounds › Other compounds · 22 Nov 2025 · 25 likes Coming back to post #8, because the follow-up matters more than the original answer. Where I would push back on the Sequence verification consensus is the confidence,…
-
Follow-up: What a seizure notice actually says Replied, post #29 · Sourcing › Logistics · 26 Oct 2025 · 2 likes The reason seizure notice keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
-
Thyroid function tests during substantial weight change Replied, post #72 · Clinical › Bloodwork · 24 Sep 2025 · 6 likes A definition problem is doing most of the work in this thyroid function tests during substantial discussion. Once the term is pinned down I suspect the disagreement…
-
Run-in periods and the population they select Replied, post #3 · Evidence › Trials · 21 Sep 2025 · 23 likes Narrowing post #2, because the general version has more than one answer. The reason run-in periods is hard to answer is that the obvious measurement and the relevant…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #23 · Data & Tools › Datasets · 20 Sep 2025 · 19 likes Self-reported, unblinded, self-selected data has known biases and is still worth collecting, provided every one of those words appears in the description.
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #63 · Evidence › Journal club · 9 Sep 2025 · 4 likes On post #61 — agreed on the reasoning, with one qualification. I would call the community position on STEP 4 likely rather than established, and I would be comfortable…
-
Asking about a compound your prescriber has not heard of Replied, post #145 · Clinical › Prescriber conversations · 1 Sep 2025 · 19 likes Bookmarking this. I will come back when I have something worth adding.
-
Needle changes between doses on a reusable pen Replied, post #30 · Devices › Pens & autoinjectors · 24 Aug 2025 · 13 likes Post #28 and I disagree about the size of the effect, not about the direction. Priming exists because the needle and the cartridge path contain air after a needle…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #37 · Compounds › Secretagogues & GH axis · 18 Aug 2025 · 0 likes On reading a rodent study I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #75 · Compounds › Oral incretins · 2 Aug 2025 · 3 likes Orforglipron is a small molecule rather than a peptide, which changes almost everything about how it is made, stored and analysed. Comparing it to oral semaglutide as…
-
A field-by-field walk through a certificate of analysis Replied, post #115 · Analytics › COA interpretation · 17 Jul 2025 · 1 like I will take the caveat as seriously as the claim, which is the point of putting it there.
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #32 · Clinical › Special populations · 30 Jun 2025 · 0 likes Checked the History of disordered eating claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting the…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #63 · Evidence › Journal club · 25 Jun 2025 · 14 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Cost per milligram, computed honestly across formats — the long version Replied, post #110 · Access › Pricing · 22 May 2025 · 3 likes I read post #106 twice before replying, because I had assumed the opposite. Nothing here is financial advice and none of it is a route to a transaction. The confident…
-
A well-designed study with a badly written abstract Replied, post #94 · Evidence › Study critique · 20 May 2025 · 0 likes A request rather than an answer: could whoever has the primary source for well-designed study post it? I have seen the claim three times this month and each version had…
-
[2026 update] Splitting an overlong document into two Replied, post #3 · Documentation › Wiki requests · 8 May 2025 · 15 likes Splitting an overlong document is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Metformin co-administration and additive GI effects Replied, post #28 · Practice › Interactions · 2 May 2025 · 32 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer.
-
Triple agonism: additive, synergistic, or neither? Replied, post #39 · Compounds › Retatrutide · 23 Apr 2025 · 32 likes This follows post #38 rather than contradicting it. Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #36 · Evidence › Journal club · 18 Apr 2025 · 6 likes Reading this STEP 1 thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #19 · Clinical › Comorbidities · 14 Apr 2025 · 26 likes Registry and observational data covering excluded populations is accumulating and is weaker evidence than a trial and better than nothing. The conclusion is tentative;…
-
Carryover and the ghost peak from last week's standard Replied, post #51 · Analytics › HPLC & UHPLC · 7 Apr 2025 · 6 likes Typical suitability criteria are a replicate area relative standard deviation below about two per cent, a tailing factor inside a defined window, a resolution minimum…
-
Second pass at: Pen dose counters: what a click does and does not guarantee Replied, post #6 · Devices › Pens & autoinjectors · 24 Mar 2025 · 4 likes Adding the measurement that post #3 says would settle it. Priming: most pens require priming before the first use (injecting a small amount to fill the needle and…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #22 · Compounds › Cagrilintide & amylin analogues · 23 Mar 2025 · 0 likes Post #20 describes the usual case. This is about the unusual one. The interest in combining it with semaglutide is that two different satiety mechanisms might add.…
-
Maintainer handover: how it works Replied, post #15 · Meta › Wiki maintenance · 13 Mar 2025 · 0 likes Worth separating two things that post #11 runs together. Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs…
-
Residual solvents and scavengers: what is looked for Replied, post #3 · Analytics › Impurities & related substances · 11 Mar 2025 · 9 likes Taking the opening post at face value and following it one step further. I would put moderate confidence on the mainstream reading of residual solvents and scavengers…
-
Washout: how long is long enough, and for what purpose Replied, post #4 · Pharmacology › Pharmacokinetics · 13 Feb 2025 · 3 likes Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense, which is why the cytochrome interaction questions that dominate small-molecule…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #71 · Analytics › COA interpretation · 28 Jan 2025 · 5 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #34 · Analytics › Mass spectrometry · 22 Jan 2025 · 22 likes Coming back to post #31, because the follow-up matters more than the original answer. An acylated peptide has a mass that reflects the modification, so comparing…
-
Follow-up: Individual participant data versus aggregate data Replied, post #33 · Evidence › Meta-analyses · 9 Jan 2025 · 18 likes Narrowing post #30, because the general version has more than one answer. When trials differ in population, duration and comparator, the pooled estimate answers a…
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #31 · Practice › Interactions · 27 Nov 2024 · 0 likes For anyone finding this later: the short answer on Grapefruit is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #117 · Compounds › Repair & healing peptides · 22 Nov 2024 · 2 likes The honest answer on reading a preclinical wound-healing model is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #19 · Evidence › Journal club · 29 Oct 2024 · 1 like Narrowing post #18, because the general version has more than one answer. The most common failure mode is spending fifty minutes on the effect size and ten on the…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #12 · Compounds › Cagrilintide & amylin analogues · 18 Oct 2024 · 0 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
Follow-up: Trifluoroacetate content and its consequences Replied, post #2 · Analytics › Impurities & related substances · 9 Oct 2024 · 7 likes The failure mode on Trifluoroacetate content is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #48 · Analytics › Method validation · 9 Oct 2024 · 11 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. The…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #45 · Devices › Syringes & needles · 6 Oct 2024 · 20 likes Reusing a needle blunts it and there is no benefit to offset that. The second injection with the same needle is the one people describe as painful. It took me longer…
-
Levothyroxine timing: a real interaction with a simple fix Started this topic · Practice › Interactions · 29 Sep 2024 · 16 likes Levothyroxine timing: a real interaction with a simple fix Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #55 · Compounds › Retatrutide · 23 Sep 2024 · 9 likes Triple agonism at GLP-1, GIP and glucagon receptors is the defining feature and the glucagon limb is the one people find counter-intuitive. It raises energy expenditure…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #8 · Analytics › COA interpretation · 7 Aug 2024 · 11 likes Since Purity assay versus content assay keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with…
-
Promotion criteria, and the one that stops most nominations Replied, post #21 · Documentation › Doc review · 20 Jul 2024 · 0 likes Everything in post #20 holds. The case it does not cover is the one I have. The most useful thing anyone has posted about promotion criteria in this category was a…
-
Two sessions a week versus four: what the evidence supports — a second dataset Replied, post #31 · Nutrition & Training › Resistance training · 12 Jul 2024 · 5 likes Nothing here is medical advice and anybody with a relevant condition should have a programme reviewed by somebody qualified rather than assembled from a forum.
-
Assessing a warm arrival: the decision process — one year on Replied, post #25 · Sourcing › Logistics · 29 May 2024 · 0 likes I had read the opposite somewhere and cannot now find where, which tells me something.